Search research articles
Contact Us
Filters
Showing results (241-250 of 260) with videos related to
Page
of 26
Sort By:
Biotechnology and Bioengineering
|
October 16, 2019
Unraveling and resolving inefficient glucolipid biosurfactants production through quantitative multiomics analyses of Starmerella bombicola strains
Sofie Lodens, Sophie L K W Roelants, Katarzyna Ciesielska, et al.
The Journal of Clinical Investigation
|
September 6, 2017
Fibroblast-specific inhibition of TGF-β1 signaling attenuates lung and tumor fibrosis
Ying Wei, Thomas J Kim, David H Peng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 2007
Efficacy and safety of single-agent pertuzumab (rhuMAb 2C4), a human epidermal growth factor receptor dimerization inhibitor, in castration-resistant prostate cancer after progression from taxane-based therapy
David B Agus, Christopher J Sweeney, Michael J Morris, et al.
Cell
|
October 18, 1996
Nomenclature: vertebrate mediators of TGFbeta family signals
R Derynck, W M Gelbart, R M Harland, et al.
Nucleic Acids Research
|
June 4, 2021
Functional characterization of RebL1 highlights the evolutionary conservation of oncogenic activities of the RBBP4/7 orthologue in Tetrahymena thermophila
Syed Nabeel-Shah, Jyoti Garg, Alejandro Saettone, et al.
Nature Communications
|
May 14, 2016
Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant
Jill M Spoerke, Steven Gendreau, Kimberly Walter, et al.
Nature Cancer
|
March 30, 2023
Precision-activated T-cell engagers targeting HER2 or EGFR and CD3 mitigate on-target, off-tumor toxicity for immunotherapy in solid tumors
Fiore Cattaruzza, Ayesha Nazeer, Milton To, et al.
Physiologia Plantarum
|
December 26, 2024
Differences in drought avoidance rather than differences in the fast versus slow growth spectrum explain distributions of two Asclepias species
Steven L Matzner, Emily R Konz, Samantha A Marts, et al.
EMBO Reports
|
September 18, 2010
Tissue-specific calibration of extracellular matrix material properties by transforming growth factor-β and Runx2 in bone is required for hearing
Jolie L Chang, Delia S Brauer, Jacob Johnson, et al.
Molecular Cancer Therapeutics
|
April 7, 2016
Plasma Metabolomic Changes following PI3K Inhibition as Pharmacodynamic Biomarkers: Preclinical Discovery to Phase I Trial Evaluation
Joo Ern Ang, Rupinder Pandher, Joo Chew Ang, et al.
Page
of 26
Search research articles
Search
Showing results (241-250 of 260) with videos related to
Sort By:
Page
of 26
Biotechnology and Bioengineering
|
October 16, 2019
Unraveling and resolving inefficient glucolipid biosurfactants production through quantitative multiomics analyses of Starmerella bombicola strains
Sofie Lodens, Sophie L K W Roelants, Katarzyna Ciesielska, et al.
The Journal of Clinical Investigation
|
September 6, 2017
Fibroblast-specific inhibition of TGF-β1 signaling attenuates lung and tumor fibrosis
Ying Wei, Thomas J Kim, David H Peng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 2007
Efficacy and safety of single-agent pertuzumab (rhuMAb 2C4), a human epidermal growth factor receptor dimerization inhibitor, in castration-resistant prostate cancer after progression from taxane-based therapy
David B Agus, Christopher J Sweeney, Michael J Morris, et al.
Cell
|
October 18, 1996
Nomenclature: vertebrate mediators of TGFbeta family signals
R Derynck, W M Gelbart, R M Harland, et al.
Nucleic Acids Research
|
June 4, 2021
Functional characterization of RebL1 highlights the evolutionary conservation of oncogenic activities of the RBBP4/7 orthologue in Tetrahymena thermophila
Syed Nabeel-Shah, Jyoti Garg, Alejandro Saettone, et al.
Nature Communications
|
May 14, 2016
Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant
Jill M Spoerke, Steven Gendreau, Kimberly Walter, et al.
Nature Cancer
|
March 30, 2023
Precision-activated T-cell engagers targeting HER2 or EGFR and CD3 mitigate on-target, off-tumor toxicity for immunotherapy in solid tumors
Fiore Cattaruzza, Ayesha Nazeer, Milton To, et al.
Physiologia Plantarum
|
December 26, 2024
Differences in drought avoidance rather than differences in the fast versus slow growth spectrum explain distributions of two Asclepias species
Steven L Matzner, Emily R Konz, Samantha A Marts, et al.
EMBO Reports
|
September 18, 2010
Tissue-specific calibration of extracellular matrix material properties by transforming growth factor-β and Runx2 in bone is required for hearing
Jolie L Chang, Delia S Brauer, Jacob Johnson, et al.
Molecular Cancer Therapeutics
|
April 7, 2016
Plasma Metabolomic Changes following PI3K Inhibition as Pharmacodynamic Biomarkers: Preclinical Discovery to Phase I Trial Evaluation
Joo Ern Ang, Rupinder Pandher, Joo Chew Ang, et al.
Page
of 26